세계의 대장균 검사 시장 : 시장 규모, 점유율, 동향 분석 - 검사별, 최종사용자별, 지역별 전망 및 예측(2024-2031년)
Global E-coli Testing Market Size, Share & Trends Analysis Report By Test (Environmental Test, and Clinical Test), By End User (Diagnostic Laboratories, Hospitals, and Physicians Offices), By Regional Outlook and Forecast, 2024 - 2031
상품코드:1534599
리서치사:KBV Research
발행일:2024년 08월
페이지 정보:영문 161 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 대장균 검사 시장 규모는 예측 기간 동안 CAGR 6.3%로 성장하여 2031년까지 31억 달러에 달할 것으로 예상됩니다.
또한 식음료 산업이 성장함에 따라 기업들은 지속적으로 신제품을 개발하고 도입하고 있습니다. 각 신제품은 대장균 및 기타 오염 물질이 포함되지 않았는지 확인하기 위해 엄격한 검사를 거쳐야 합니다. 신제품 라인의 안전성에 대한 이러한 수요는 대장균 검사 시장의 성장에 기여하고 있습니다. 따라서 성장하는 식음료 산업이 성장을 주도하고 있습니다.
그러나 분자진단(PCR 등), 차세대 염기서열 분석(NGS), 자동화 시스템 등 첨단 검사 기술에는 많은 자금 투자가 필요한 경우가 많습니다. 여기에는 장비 구매, 유지보수 및 조정, 장비의 효과적인 사용을 위한 인력 교육에 드는 비용이 포함됩니다.
검사 전망
검사를 기준으로 시장은 환경 검사와 임상 검사로 나뉩니다. 임상 검사 부문은 2023년 시장에서 32%의 매출 점유율을 기록했습니다. 요로감염증(UTI), 혈류감염증, 위장병 등 대장균 관련 감염증이 증가하고 있습니다.
최종 용도 전망
최종사용자를 기준으로 시장은 병원, 진단 실험실, 클리닉으로 나뉘며, 2023년에는 진단 실험실 부문이 시장에서 43%의 매출 점유율을 차지할 것으로 예상됩니다. 병원에서는 다양한 병을 앓고있는 환자가 많이 방문하기 때문에 대장균 감염이 발생할 가능성이 높습니다.
지역 전망
지역별로 보면 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카에 걸쳐 분석되었으며, 2023년 아시아태평양은 시장에서 25%의 매출 점유율을 차지했습니다. 아시아태평양은 급속한 도시화와 산업화로 인해 수자원의 오염과 오염이 증가할 수 있습니다.
목차
제1장 시장 범위와 조사 방법
시장 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 요람
주요 하이라이트
제3장 시장 개요
소개
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
시장 과제
Porter's Five Forces 분석
제4장 세계의 대장균 검사 시장 : 검사별
세계의 환경 검사 시장 : 지역별
세계의 임상 검사 시장 : 지역별
제5장 세계의 대장균 검사 시장 : 최종사용자별
세계의 진단 검사실 시장 : 지역별
세계의 병원 시장 : 지역별
세계의 의사 오피스 시장 : 지역별
제6장 세계의 대장균 검사 시장 : 지역별
북미
북미 시장 : 국가별
미국
캐나다
멕시코
기타 북미
유럽
유럽 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽
아시아태평양
아시아태평양 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카, 중동 및 아프리카
라틴아메리카, 중동 및 아프리카 시장 : 국가별
브라질
아르헨티나
아랍에미리트
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카, 중동 및 아프리카
제7장 기업 개요
Pro Lab Diagnostics Inc
NanoLogix, Inc
CPI International
BioMerieux
Thermo Fisher Scientific, Inc
Bio-Rad laboratories, Inc
Meridian Bioscience, Inc(SD Biosensor Co., Ltd.)
Becton, Dickinson, and Company
IDEXX Laboratories, Inc
제8장 대장균 검사 시장의 성공 필수 조건
ksm
영문 목차
영문목차
The Global E-coli Testing Market size is expected to reach $3.1 billion by 2031, rising at a market growth of 6.3% CAGR during the forecast period.
North America has experienced notable outbreaks of food-borne illnesses linked to E-coli contamination in foods like ground beef, leafy greens, and other produce. This has heightened the demand for routine E-coli testing in the food industry to prevent outbreaks and protect public health. The region has a well-developed healthcare infrastructure with numerous hospitals, clinics, and diagnostic laboratories equipped with advanced diagnostic technologies. The high healthcare delivery and diagnostic testing capacity contributes to the significant demand for E-coli testing. Thus, the North America region segment acquired 39% revenue share in the market 2023.
Personalized medicine approaches involve close monitoring and management for individuals with chronic or recurrent E-coli infections. Advanced E-coli testing technologies enable regular and detailed assessment of infection status, allowing for personalized treatment and adjustments to management strategies.
Additionally, companies continuously develop and introduce new products as the food and beverage industry grows. Each new product requires rigorous testing to ensure it is free from E-coli and other contaminants. This demand for safety in new product lines contributes to the growth of the E-coli testing market. Therefore, the growing food and beverage industry is driving growth.
However, advanced testing technologies, such as molecular diagnostics (e.g., PCR), next-generation sequencing (NGS), and automated systems, often require substantial financial investment. This includes costs for purchasing equipment, maintaining and calibrating it, and training personnel to use it effectively.
Test Outlook
Based on the test, the market is divided into environmental test and clinical test. The clinical test segment witnessed 32% revenue share in the market in 2023. E-coli-related infections are increasing, including urinary tract infections (UTIs), bloodstream infections, and gastrointestinal illnesses.
End-Use Outlook
On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, and physicians' offices. In 2023, the diagnostic laboratories segment attained 43% revenue share in the market. Hospitals experience a high volume of patients with diverse medical conditions, increasing the likelihood of encountering E-coli infections.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 25% revenue share in the market. The Asia Pacific region is experiencing rapid urbanization and industrialization, which can lead to increased pollution and contamination of water sources.
List of Key Companies Profiled
BIOMERIEUX
Bio-Rad Laboratories, Inc.
Pro Lab diagnostics
NanoLogix, Inc.
Thermo Fisher Scientific
CPI International
Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
Becton, Dickinson and Company
IDEXX Laboratories, Inc.
Global E-coli Testing Market Report Segmentation
By Test
Environmental Test
Clinical Test
By End User
Diagnostic Laboratories
Hospitals
Physicians Offices
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global E-coli Testing Market, by Test
1.4.2 Global E-coli Testing Market, by End User
1.4.3 Global E-coli Testing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global E-coli Testing Market by Test
4.1 Global Environmental Test Market by Region
4.2 Global Clinical Test Market by Region
Chapter 5. Global E-coli Testing Market by End User
5.1 Global Diagnostic Laboratories Market by Region
5.2 Global Hospitals Market by Region
5.3 Global Physicians Offices Market by Region
Chapter 6. Global E-coli Testing Market by Region
6.1 North America E-coli Testing Market
6.1.1 North America E-coli Testing Market by Test
6.1.1.1 North America Environmental Test Market by Region
6.1.1.2 North America Clinical Test Market by Region
6.1.2 North America E-coli Testing Market by End User
6.1.2.1 North America Diagnostic Laboratories Market by Country
6.1.2.2 North America Hospitals Market by Country
6.1.2.3 North America Physicians Offices Market by Country
6.1.3 North America E-coli Testing Market by Country
6.1.3.1 US E-coli Testing Market
6.1.3.1.1 US E-coli Testing Market by Test
6.1.3.1.2 US E-coli Testing Market by End User
6.1.3.2 Canada E-coli Testing Market
6.1.3.2.1 Canada E-coli Testing Market by Test
6.1.3.2.2 Canada E-coli Testing Market by End User
6.1.3.3 Mexico E-coli Testing Market
6.1.3.3.1 Mexico E-coli Testing Market by Test
6.1.3.3.2 Mexico E-coli Testing Market by End User
6.1.3.4 Rest of North America E-coli Testing Market
6.1.3.4.1 Rest of North America E-coli Testing Market by Test
6.1.3.4.2 Rest of North America E-coli Testing Market by End User
6.2 Europe E-coli Testing Market
6.2.1 Europe E-coli Testing Market by Test
6.2.1.1 Europe Environmental Test Market by Country
6.2.1.2 Europe Clinical Test Market by Country
6.2.2 Europe E-coli Testing Market by End User
6.2.2.1 Europe Diagnostic Laboratories Market by Country
6.2.2.2 Europe Hospitals Market by Country
6.2.2.3 Europe Physicians Offices Market by Country
6.2.3 Europe E-coli Testing Market by Country
6.2.3.1 Germany E-coli Testing Market
6.2.3.1.1 Germany E-coli Testing Market by Test
6.2.3.1.2 Germany E-coli Testing Market by End User
6.2.3.2 UK E-coli Testing Market
6.2.3.2.1 UK E-coli Testing Market by Test
6.2.3.2.2 UK E-coli Testing Market by End User
6.2.3.3 France E-coli Testing Market
6.2.3.3.1 France E-coli Testing Market by Test
6.2.3.3.2 France E-coli Testing Market by End User
6.2.3.4 Russia E-coli Testing Market
6.2.3.4.1 Russia E-coli Testing Market by Test
6.2.3.4.2 Russia E-coli Testing Market by End User
6.2.3.5 Spain E-coli Testing Market
6.2.3.5.1 Spain E-coli Testing Market by Test
6.2.3.5.2 Spain E-coli Testing Market by End User
6.2.3.6 Italy E-coli Testing Market
6.2.3.6.1 Italy E-coli Testing Market by Test
6.2.3.6.2 Italy E-coli Testing Market by End User
6.2.3.7 Rest of Europe E-coli Testing Market
6.2.3.7.1 Rest of Europe E-coli Testing Market by Test
6.2.3.7.2 Rest of Europe E-coli Testing Market by End User
6.3 Asia Pacific E-coli Testing Market
6.3.1 Asia Pacific E-coli Testing Market by Test
6.3.1.1 Asia Pacific Environmental Test Market by Country
6.3.1.2 Asia Pacific Clinical Test Market by Country
6.3.2 Asia Pacific E-coli Testing Market by End User
6.3.2.1 Asia Pacific Diagnostic Laboratories Market by Country
6.3.2.2 Asia Pacific Hospitals Market by Country
6.3.2.3 Asia Pacific Physicians Offices Market by Country
6.3.3 Asia Pacific E-coli Testing Market by Country
6.3.3.1 China E-coli Testing Market
6.3.3.1.1 China E-coli Testing Market by Test
6.3.3.1.2 China E-coli Testing Market by End User
6.3.3.2 Japan E-coli Testing Market
6.3.3.2.1 Japan E-coli Testing Market by Test
6.3.3.2.2 Japan E-coli Testing Market by End User
6.3.3.3 India E-coli Testing Market
6.3.3.3.1 India E-coli Testing Market by Test
6.3.3.3.2 India E-coli Testing Market by End User
6.3.3.4 South Korea E-coli Testing Market
6.3.3.4.1 South Korea E-coli Testing Market by Test
6.3.3.4.2 South Korea E-coli Testing Market by End User
6.3.3.5 Singapore E-coli Testing Market
6.3.3.5.1 Singapore E-coli Testing Market by Test
6.3.3.5.2 Singapore E-coli Testing Market by End User
6.3.3.6 Malaysia E-coli Testing Market
6.3.3.6.1 Malaysia E-coli Testing Market by Test
6.3.3.6.2 Malaysia E-coli Testing Market by End User
6.3.3.7 Rest of Asia Pacific E-coli Testing Market
6.3.3.7.1 Rest of Asia Pacific E-coli Testing Market by Test
6.3.3.7.2 Rest of Asia Pacific E-coli Testing Market by End User
6.4 LAMEA E-coli Testing Market
6.4.1 LAMEA E-coli Testing Market by Test
6.4.1.1 LAMEA Environmental Test Market by Country
6.4.1.2 LAMEA Clinical Test Market by Country
6.4.2 LAMEA E-coli Testing Market by End User
6.4.2.1 LAMEA Diagnostic Laboratories Market by Country
6.4.2.2 LAMEA Hospitals Market by Country
6.4.2.3 LAMEA Physicians Offices Market by Country
6.4.3 LAMEA E-coli Testing Market by Country
6.4.3.1 Brazil E-coli Testing Market
6.4.3.1.1 Brazil E-coli Testing Market by Test
6.4.3.1.2 Brazil E-coli Testing Market by End User
6.4.3.2 Argentina E-coli Testing Market
6.4.3.2.1 Argentina E-coli Testing Market by Test
6.4.3.2.2 Argentina E-coli Testing Market by End User
6.4.3.3 UAE E-coli Testing Market
6.4.3.3.1 UAE E-coli Testing Market by Test
6.4.3.3.2 UAE E-coli Testing Market by End User
6.4.3.4 Saudi Arabia E-coli Testing Market
6.4.3.4.1 Saudi Arabia E-coli Testing Market by Test
6.4.3.4.2 Saudi Arabia E-coli Testing Market by End User
6.4.3.5 South Africa E-coli Testing Market
6.4.3.5.1 South Africa E-coli Testing Market by Test
6.4.3.5.2 South Africa E-coli Testing Market by End User
6.4.3.6 Nigeria E-coli Testing Market
6.4.3.6.1 Nigeria E-coli Testing Market by Test
6.4.3.6.2 Nigeria E-coli Testing Market by End User
6.4.3.7 Rest of LAMEA E-coli Testing Market
6.4.3.7.1 Rest of LAMEA E-coli Testing Market by Test
6.4.3.7.2 Rest of LAMEA E-coli Testing Market by End User
Chapter 7. Company Profiles
7.1 Pro Lab Diagnostics Inc.
7.1.1 Company Overview
7.2 NanoLogix, Inc.
7.2.1 Company Overview
7.3 CPI International
7.3.1 Company Overview
7.4 BioMerieux
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Bio-Rad laboratories, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Meridian Bioscience, Inc. (SD Biosensor Co., Ltd.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.8 Becton, Dickinson, and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 SWOT Analysis
7.9 IDEXX Laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 SWOT Analysis
Chapter 8. Winning Imperatives for E-coli Testing Market
